Exclusive Rights or Market Abuse? Supreme Court to Clarify CCI’s Reach in Patent Disputes

The Supreme Court of India has reopened one of the most contentious questions at the intersection of competition law and intellectual property law: Can the Competition Commission of India (CCI) examine allegations of abuse of dominance when such allegations arise from the exercise of patent rights?

Contents

Background: The Vifor–Ferric Carboxymaltose Dispute NCLAT’s Reasoning: Patents Act as a Special Statute The Ericsson–Monsanto Precedents: The Root of the Controversy The Core Legal Issue Before the Supreme Court Competition Law vs Patent Law: Conflict or Coexistence?Why the Supreme Court’s Decision Matters Conclusion: Awaiting a Definitive Resolution

In Competition Commission of India v. Swapna Dey, a Bench comprising Justices J.B. Pardiwala and Vijay Bishnoi has stayed key portions of a National Company Law Appellate Tribunal (NCLAT) ruling which held that the Competition Act, 2002 does not apply to disputes involving the exercise of patent rights. The Supreme Court has clarified that it will decide the matter strictly on the question of jurisdiction, without reopening the merits of the underlying dispute.

This development is significant because it may finally resolve the institutional tussle between the CCI and patent authorities, a conflict that has persisted for over a decade.

Background: The Vifor–Ferric Carboxymaltose Dispute

The appeal before the Supreme Court arises from an NCLAT order dismissing a challenge to a 2022 CCI decision that closed a complaint against Vifor International AG, a Swiss pharmaceutical company. The complaint related to alleged abuse of dominance concerning Ferric Carboxymaltose (FCM), a patented drug used to treat iron deficiency.

While the CCI closed the case on merits, the NCLAT went a step further and held that the CCI lacked jurisdiction altogether. According to the Appellate Tribunal, disputes involving the exercise of patent rights fall exclusively within the domain of the Patents Act, 1970, which it described as a special and complete code.

It is this sweeping jurisdictional finding that the Supreme Court has now stayed.

NCLAT’s Reasoning: Patents Act as a Special Statute

The NCLAT’s conclusion rested on three principal grounds:

Section 3(5) of the Competition Act, 2002, which protects reasonable conditions imposed by IP holders for the protection of their statutory rights.
The Delhi High Court Division Bench ruling (2023) in the Ericsson–Monsanto line of cases, which held that the CCI cannot investigate abuse of dominance claims rooted in the exercise of patent rights.
The fact that the Supreme Court had earlier declined to interfere with the Delhi High Court’s ruling, albeit while keeping broader questions of law open.

On this basis, the NCLAT ruled that once alleged anti-competitive conduct arises from patent licensing, royalty fixation, or enforcement, the Competition Act stands excluded.

The Ericsson–Monsanto Precedents: The Root of the Controversy

The present controversy traces its origins to the well-known Ericsson SEP disputes.

In Telefonaktiebolaget LM Ericsson v. Micromax and Intex, Indian handset manufacturers alleged that Ericsson abused its dominant position by demanding excessive and discriminatory royalties for its Standard Essential Patents (SEPs). The CCI formed a prima facie opinion of abuse and ordered an investigation.

Ericsson challenged the CCI’s jurisdiction, arguing that:

Issues of patent licensing and royalty determination fall under the Patents Act, 1970, and
The Act already provides remedies such as compulsory licensing and revocation.

While a single judge of the Delhi High Court initially allowed the CCI’s investigation to proceed at the preliminary stage, a Division Bench in 2023 overturned that view. It held that:

The Patents Act is a special law and complete code,
Allegations of abuse of patent rights must be addressed under the Patents Act, and
The CCI has no jurisdiction in such cases.

This reasoning was later extended to the Monsanto matter and has since shaped NCLAT jurisprudence.

The Core Legal Issue Before the Supreme Court

The Supreme Court has made it clear that it will examine only one narrow but crucial question:

Does the Competition Commission of India have jurisdiction to examine competition law violations arising from the exercise of patent rights?

Importantly:

The Court has stayed only the NCLAT’s jurisdictional findings.
The merits of the Vifor dispute will not be reopened.
The outcome will determine the future scope of CCI oversight over IP-related conduct.

Competition Law vs Patent Law: Conflict or Coexistence?

At the heart of the dispute lies a fundamental policy tension.

Arguments Against CCI Jurisdiction

The Patents Act, 1970 already addresses unreasonable licensing through compulsory licensing provisions.
Patent law involves technical assessments better handled by specialised forums.
Section 3(5) of the Competition Act protects reasonable IP exploitation.

Arguments Supporting CCI Jurisdiction

Patent rights are not absolute and cannot legitimise anti-competitive conduct.
Competition law addresses market effects, not patent validity.
Excluding CCI oversight risks monopolistic abuse, especially in pharmaceutical and technology markets.

Globally, jurisdictions such as the EU and the US allow competition authorities to scrutinise patent-based conduct where market dominance and consumer harm are alleged.

Why the Supreme Court’s Decision Matters

The Supreme Court’s ruling will have far-reaching consequences:

For innovation markets: Especially pharmaceuticals, telecom, and digital technologies.
For regulatory overlap: Clarifying whether competition law and patent law operate in silos or in tandem.
For access to medicines and technology: Determining whether excessive pricing and exclusionary licensing can be examined by competition regulators.

A finding in favour of CCI jurisdiction would restore regulatory oversight over abuse of dominance cloaked as patent enforcement. Conversely, affirming the NCLAT view may significantly narrow the scope of Indian competition law.

Conclusion: Awaiting a Definitive Resolution

The Supreme Court’s decision in CCI v. Swapna Dey presents an opportunity to conclusively settle a long-standing jurisdictional impasse. By confining itself to the question of law, the Court is poised to clarify whether intellectual property rights and competition law are mutually exclusive or complementary regulatory regimes.

Whatever the outcome, the ruling will reshape how Indian law balances innovation incentives with market fairness, and will determine the future role of the CCI in policing anti-competitive conduct arising from patent monopolies.